HUTCHMED (China) Limited
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $456.9M | $37.7M | $100.8M | $-360.8M | $-194.6M | $-125.7M | $-106.0M | $-74.8M |
| Depreciation & Amortization | $13.3M | $12.3M | $8.2M | $8.7M | $7.2M | $6.1M | $4.9M | $3.6M |
| Depreciation | $12.0M | $12.1M | $7.9M | $8.3M | $6.8M | $5.9M | $4.8M | $3.5M |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-64.7M | $497.0K | $219.3M | $-268.6M | $-204.2M | $-62.1M | $-80.9M | $-32.8M |
| Investing Activities | ||||||||
| Capital Expenditures | $14.1M | $17.9M | $32.6M | $36.7M | $16.4M | $7.9M | $8.6M | $6.4M |
| Business Acquisitions | — | — | — | — | — | — | $8.1M | — |
| Net Cash from Investing Activities | $-29.4M | $-96.1M | $-291.1M | $296.6M | $-306.3M | $-125.4M | $119.0M | $43.8M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | $36.1M | $9.1M | $48.1M | $27.3M | $12.9M | $346.0K | $5.5M |
| Net Cash from Financing Activities | $7.8M | $-30.7M | $48.7M | $-82.8M | $650.0M | $296.4M | $-1.5M | $-8.2M |
| Net Change in Cash | $-82.6M | $-129.6M | $-29.7M | $-64.3M | $141.9M | $114.5M | $35.1M | $771.0K |
| Free Cash Flow | $-78.8M | $-17.4M | $186.6M | $-305.3M | $-220.6M | $-70.0M | $-89.5M | $-39.2M |